1 Study Coverage
    1.1 Pentavalent Antimonials Product Introduction
    1.2 Market by Type
        1.2.1 Global Pentavalent Antimonials Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Sodium Stibogluconate
        1.2.3 Meglumine Antimoniate
    1.3 Market by Application
        1.3.1 Global Pentavalent Antimonials Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Pentavalent Antimonials Sales Estimates and Forecasts 2017-2028
    2.2 Global Pentavalent Antimonials Revenue Estimates and Forecasts 2017-2028
    2.3 Global Pentavalent Antimonials Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Pentavalent Antimonials Sales by Region
        2.4.1 Global Pentavalent Antimonials Sales by Region (2017-2022)
        2.4.2 Global Sales Pentavalent Antimonials by Region (2023-2028)
    2.5 Global Pentavalent Antimonials Revenue by Region
        2.5.1 Global Pentavalent Antimonials Revenue by Region (2017-2022)
        2.5.2 Global Pentavalent Antimonials Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Pentavalent Antimonials Sales by Manufacturers
        3.1.1 Global Top Pentavalent Antimonials Manufacturers by Sales (2017-2022)
        3.1.2 Global Pentavalent Antimonials Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pentavalent Antimonials in 2021
    3.2 Global Pentavalent Antimonials Revenue by Manufacturers
        3.2.1 Global Pentavalent Antimonials Revenue by Manufacturers (2017-2022)
        3.2.2 Global Pentavalent Antimonials Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Pentavalent Antimonials Revenue in 2021
    3.3 Global Pentavalent Antimonials Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Pentavalent Antimonials Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Pentavalent Antimonials Sales by Type
        4.1.1 Global Pentavalent Antimonials Historical Sales by Type (2017-2022)
        4.1.2 Global Pentavalent Antimonials Forecasted Sales by Type (2023-2028)
        4.1.3 Global Pentavalent Antimonials Sales Market Share by Type (2017-2028)
    4.2 Global Pentavalent Antimonials Revenue by Type
        4.2.1 Global Pentavalent Antimonials Historical Revenue by Type (2017-2022)
        4.2.2 Global Pentavalent Antimonials Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Pentavalent Antimonials Revenue Market Share by Type (2017-2028)
    4.3 Global Pentavalent Antimonials Price by Type
        4.3.1 Global Pentavalent Antimonials Price by Type (2017-2022)
        4.3.2 Global Pentavalent Antimonials Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Pentavalent Antimonials Sales by Application
        5.1.1 Global Pentavalent Antimonials Historical Sales by Application (2017-2022)
        5.1.2 Global Pentavalent Antimonials Forecasted Sales by Application (2023-2028)
        5.1.3 Global Pentavalent Antimonials Sales Market Share by Application (2017-2028)
    5.2 Global Pentavalent Antimonials Revenue by Application
        5.2.1 Global Pentavalent Antimonials Historical Revenue by Application (2017-2022)
        5.2.2 Global Pentavalent Antimonials Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Pentavalent Antimonials Revenue Market Share by Application (2017-2028)
    5.3 Global Pentavalent Antimonials Price by Application
        5.3.1 Global Pentavalent Antimonials Price by Application (2017-2022)
        5.3.2 Global Pentavalent Antimonials Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Pentavalent Antimonials Market Size by Type
        6.1.1 North America Pentavalent Antimonials Sales by Type (2017-2028)
        6.1.2 North America Pentavalent Antimonials Revenue by Type (2017-2028)
    6.2 North America Pentavalent Antimonials Market Size by Application
        6.2.1 North America Pentavalent Antimonials Sales by Application (2017-2028)
        6.2.2 North America Pentavalent Antimonials Revenue by Application (2017-2028)
    6.3 North America Pentavalent Antimonials Market Size by Country
        6.3.1 North America Pentavalent Antimonials Sales by Country (2017-2028)
        6.3.2 North America Pentavalent Antimonials Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Pentavalent Antimonials Market Size by Type
        7.1.1 Europe Pentavalent Antimonials Sales by Type (2017-2028)
        7.1.2 Europe Pentavalent Antimonials Revenue by Type (2017-2028)
    7.2 Europe Pentavalent Antimonials Market Size by Application
        7.2.1 Europe Pentavalent Antimonials Sales by Application (2017-2028)
        7.2.2 Europe Pentavalent Antimonials Revenue by Application (2017-2028)
    7.3 Europe Pentavalent Antimonials Market Size by Country
        7.3.1 Europe Pentavalent Antimonials Sales by Country (2017-2028)
        7.3.2 Europe Pentavalent Antimonials Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Pentavalent Antimonials Market Size by Type
        8.1.1 Asia Pacific Pentavalent Antimonials Sales by Type (2017-2028)
        8.1.2 Asia Pacific Pentavalent Antimonials Revenue by Type (2017-2028)
    8.2 Asia Pacific Pentavalent Antimonials Market Size by Application
        8.2.1 Asia Pacific Pentavalent Antimonials Sales by Application (2017-2028)
        8.2.2 Asia Pacific Pentavalent Antimonials Revenue by Application (2017-2028)
    8.3 Asia Pacific Pentavalent Antimonials Market Size by Region
        8.3.1 Asia Pacific Pentavalent Antimonials Sales by Region (2017-2028)
        8.3.2 Asia Pacific Pentavalent Antimonials Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Pentavalent Antimonials Market Size by Type
        9.1.1 Latin America Pentavalent Antimonials Sales by Type (2017-2028)
        9.1.2 Latin America Pentavalent Antimonials Revenue by Type (2017-2028)
    9.2 Latin America Pentavalent Antimonials Market Size by Application
        9.2.1 Latin America Pentavalent Antimonials Sales by Application (2017-2028)
        9.2.2 Latin America Pentavalent Antimonials Revenue by Application (2017-2028)
    9.3 Latin America Pentavalent Antimonials Market Size by Country
        9.3.1 Latin America Pentavalent Antimonials Sales by Country (2017-2028)
        9.3.2 Latin America Pentavalent Antimonials Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Pentavalent Antimonials Market Size by Type
        10.1.1 Middle East and Africa Pentavalent Antimonials Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Pentavalent Antimonials Revenue by Type (2017-2028)
    10.2 Middle East and Africa Pentavalent Antimonials Market Size by Application
        10.2.1 Middle East and Africa Pentavalent Antimonials Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Pentavalent Antimonials Revenue by Application (2017-2028)
    10.3 Middle East and Africa Pentavalent Antimonials Market Size by Country
        10.3.1 Middle East and Africa Pentavalent Antimonials Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Pentavalent Antimonials Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Corporation Information
        11.1.2 Sanofi Overview
        11.1.3 Sanofi Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Recent Developments
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Corporation Information
        11.2.2 GlaxoSmithKline Overview
        11.2.3 GlaxoSmithKline Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GlaxoSmithKline Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GlaxoSmithKline Recent Developments
    11.3 Bristol-Myers Squibb
        11.3.1 Bristol-Myers Squibb Corporation Information
        11.3.2 Bristol-Myers Squibb Overview
        11.3.3 Bristol-Myers Squibb Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bristol-Myers Squibb Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bristol-Myers Squibb Recent Developments
    11.4 Maiden Pharmaceuticals
        11.4.1 Maiden Pharmaceuticals Corporation Information
        11.4.2 Maiden Pharmaceuticals Overview
        11.4.3 Maiden Pharmaceuticals Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Maiden Pharmaceuticals Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Maiden Pharmaceuticals Recent Developments
    11.5 Xinhua Pharm
        11.5.1 Xinhua Pharm Corporation Information
        11.5.2 Xinhua Pharm Overview
        11.5.3 Xinhua Pharm Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Xinhua Pharm Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Xinhua Pharm Recent Developments
    11.6 Albert David
        11.6.1 Albert David Corporation Information
        11.6.2 Albert David Overview
        11.6.3 Albert David Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Albert David Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Albert David Recent Developments
    11.7 Science Direct
        11.7.1 Science Direct Corporation Information
        11.7.2 Science Direct Overview
        11.7.3 Science Direct Pentavalent Antimonials Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Science Direct Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Science Direct Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Pentavalent Antimonials Industry Chain Analysis
    12.2 Pentavalent Antimonials Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Pentavalent Antimonials Production Mode & Process
    12.4 Pentavalent Antimonials Sales and Marketing
        12.4.1 Pentavalent Antimonials Sales Channels
        12.4.2 Pentavalent Antimonials Distributors
    12.5 Pentavalent Antimonials Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Pentavalent Antimonials Industry Trends
    13.2 Pentavalent Antimonials Market Drivers
    13.3 Pentavalent Antimonials Market Challenges
    13.4 Pentavalent Antimonials Market Restraints
14 Key Findings in The Global Pentavalent Antimonials Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Pentavalent Antimonials Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Sodium Stibogluconate
    Table 3. Major Manufacturers of Meglumine Antimoniate
    Table 4. Global Pentavalent Antimonials Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Pentavalent Antimonials Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Pentavalent Antimonials Sales by Region (2017-2022) & (g)
    Table 7. Global Pentavalent Antimonials Sales Market Share by Region (2017-2022)
    Table 8. Global Pentavalent Antimonials Sales by Region (2023-2028) & (g)
    Table 9. Global Pentavalent Antimonials Sales Market Share by Region (2023-2028)
    Table 10. Global Pentavalent Antimonials Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Pentavalent Antimonials Revenue Market Share by Region (2017-2022)
    Table 12. Global Pentavalent Antimonials Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Pentavalent Antimonials Revenue Market Share by Region (2023-2028)
    Table 14. Global Pentavalent Antimonials Sales by Manufacturers (2017-2022) & (g)
    Table 15. Global Pentavalent Antimonials Sales Share by Manufacturers (2017-2022)
    Table 16. Global Pentavalent Antimonials Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Pentavalent Antimonials Revenue Share by Manufacturers (2017-2022)
    Table 18. Pentavalent Antimonials Price by Manufacturers (2017-2022) &(USD/mg)
    Table 19. Global Pentavalent Antimonials Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Pentavalent Antimonials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pentavalent Antimonials as of 2021)
    Table 21. Pentavalent Antimonials Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Pentavalent Antimonials Product Offered
    Table 23. Date of Manufacturers Enter into Pentavalent Antimonials Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pentavalent Antimonials Sales by Type (2017-2022) & (g)
    Table 26. Global Pentavalent Antimonials Sales by Type (2023-2028) & (g)
    Table 27. Global Pentavalent Antimonials Sales Share by Type (2017-2022)
    Table 28. Global Pentavalent Antimonials Sales Share by Type (2023-2028)
    Table 29. Global Pentavalent Antimonials Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Pentavalent Antimonials Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Pentavalent Antimonials Revenue Share by Type (2017-2022)
    Table 32. Global Pentavalent Antimonials Revenue Share by Type (2023-2028)
    Table 33. Pentavalent Antimonials Price by Type (2017-2022) & (USD/mg)
    Table 34. Global Pentavalent Antimonials Price Forecast by Type (2023-2028) & (USD/mg)
    Table 35. Global Pentavalent Antimonials Sales by Application (2017-2022) & (g)
    Table 36. Global Pentavalent Antimonials Sales by Application (2023-2028) & (g)
    Table 37. Global Pentavalent Antimonials Sales Share by Application (2017-2022)
    Table 38. Global Pentavalent Antimonials Sales Share by Application (2023-2028)
    Table 39. Global Pentavalent Antimonials Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Pentavalent Antimonials Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Pentavalent Antimonials Revenue Share by Application (2017-2022)
    Table 42. Global Pentavalent Antimonials Revenue Share by Application (2023-2028)
    Table 43. Pentavalent Antimonials Price by Application (2017-2022) & (USD/mg)
    Table 44. Global Pentavalent Antimonials Price Forecast by Application (2023-2028) & (USD/mg)
    Table 45. North America Pentavalent Antimonials Sales by Type (2017-2022) & (g)
    Table 46. North America Pentavalent Antimonials Sales by Type (2023-2028) & (g)
    Table 47. North America Pentavalent Antimonials Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Pentavalent Antimonials Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Pentavalent Antimonials Sales by Application (2017-2022) & (g)
    Table 50. North America Pentavalent Antimonials Sales by Application (2023-2028) & (g)
    Table 51. North America Pentavalent Antimonials Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Pentavalent Antimonials Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Pentavalent Antimonials Sales by Country (2017-2022) & (g)
    Table 54. North America Pentavalent Antimonials Sales by Country (2023-2028) & (g)
    Table 55. North America Pentavalent Antimonials Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Pentavalent Antimonials Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Pentavalent Antimonials Sales by Type (2017-2022) & (g)
    Table 58. Europe Pentavalent Antimonials Sales by Type (2023-2028) & (g)
    Table 59. Europe Pentavalent Antimonials Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Pentavalent Antimonials Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Pentavalent Antimonials Sales by Application (2017-2022) & (g)
    Table 62. Europe Pentavalent Antimonials Sales by Application (2023-2028) & (g)
    Table 63. Europe Pentavalent Antimonials Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Pentavalent Antimonials Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Pentavalent Antimonials Sales by Country (2017-2022) & (g)
    Table 66. Europe Pentavalent Antimonials Sales by Country (2023-2028) & (g)
    Table 67. Europe Pentavalent Antimonials Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Pentavalent Antimonials Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Pentavalent Antimonials Sales by Type (2017-2022) & (g)
    Table 70. Asia Pacific Pentavalent Antimonials Sales by Type (2023-2028) & (g)
    Table 71. Asia Pacific Pentavalent Antimonials Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Pentavalent Antimonials Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Pentavalent Antimonials Sales by Application (2017-2022) & (g)
    Table 74. Asia Pacific Pentavalent Antimonials Sales by Application (2023-2028) & (g)
    Table 75. Asia Pacific Pentavalent Antimonials Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Pentavalent Antimonials Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Pentavalent Antimonials Sales by Region (2017-2022) & (g)
    Table 78. Asia Pacific Pentavalent Antimonials Sales by Region (2023-2028) & (g)
    Table 79. Asia Pacific Pentavalent Antimonials Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Pentavalent Antimonials Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Pentavalent Antimonials Sales by Type (2017-2022) & (g)
    Table 82. Latin America Pentavalent Antimonials Sales by Type (2023-2028) & (g)
    Table 83. Latin America Pentavalent Antimonials Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Pentavalent Antimonials Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Pentavalent Antimonials Sales by Application (2017-2022) & (g)
    Table 86. Latin America Pentavalent Antimonials Sales by Application (2023-2028) & (g)
    Table 87. Latin America Pentavalent Antimonials Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Pentavalent Antimonials Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Pentavalent Antimonials Sales by Country (2017-2022) & (g)
    Table 90. Latin America Pentavalent Antimonials Sales by Country (2023-2028) & (g)
    Table 91. Latin America Pentavalent Antimonials Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Pentavalent Antimonials Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Pentavalent Antimonials Sales by Type (2017-2022) & (g)
    Table 94. Middle East and Africa Pentavalent Antimonials Sales by Type (2023-2028) & (g)
    Table 95. Middle East and Africa Pentavalent Antimonials Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Pentavalent Antimonials Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Pentavalent Antimonials Sales by Application (2017-2022) & (g)
    Table 98. Middle East and Africa Pentavalent Antimonials Sales by Application (2023-2028) & (g)
    Table 99. Middle East and Africa Pentavalent Antimonials Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Pentavalent Antimonials Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Pentavalent Antimonials Sales by Country (2017-2022) & (g)
    Table 102. Middle East and Africa Pentavalent Antimonials Sales by Country (2023-2028) & (g)
    Table 103. Middle East and Africa Pentavalent Antimonials Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Pentavalent Antimonials Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Sanofi Corporation Information
    Table 106. Sanofi Description and Major Businesses
    Table 107. Sanofi Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
    Table 108. Sanofi Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Sanofi Recent Developments
    Table 110. GlaxoSmithKline Corporation Information
    Table 111. GlaxoSmithKline Description and Major Businesses
    Table 112. GlaxoSmithKline Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
    Table 113. GlaxoSmithKline Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GlaxoSmithKline Recent Developments
    Table 115. Bristol-Myers Squibb Corporation Information
    Table 116. Bristol-Myers Squibb Description and Major Businesses
    Table 117. Bristol-Myers Squibb Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
    Table 118. Bristol-Myers Squibb Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Bristol-Myers Squibb Recent Developments
    Table 120. Maiden Pharmaceuticals Corporation Information
    Table 121. Maiden Pharmaceuticals Description and Major Businesses
    Table 122. Maiden Pharmaceuticals Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
    Table 123. Maiden Pharmaceuticals Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Maiden Pharmaceuticals Recent Developments
    Table 125. Xinhua Pharm Corporation Information
    Table 126. Xinhua Pharm Description and Major Businesses
    Table 127. Xinhua Pharm Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
    Table 128. Xinhua Pharm Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Xinhua Pharm Recent Developments
    Table 130. Albert David Corporation Information
    Table 131. Albert David Description and Major Businesses
    Table 132. Albert David Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
    Table 133. Albert David Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Albert David Recent Developments
    Table 135. Science Direct Corporation Information
    Table 136. Science Direct Description and Major Businesses
    Table 137. Science Direct Pentavalent Antimonials Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2017-2022)
    Table 138. Science Direct Pentavalent Antimonials Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Science Direct Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Pentavalent Antimonials Distributors List
    Table 143. Pentavalent Antimonials Customers List
    Table 144. Pentavalent Antimonials Market Trends
    Table 145. Pentavalent Antimonials Market Drivers
    Table 146. Pentavalent Antimonials Market Challenges
    Table 147. Pentavalent Antimonials Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pentavalent Antimonials Product Picture
    Figure 3. Global Pentavalent Antimonials Market Share by Type in 2021 & 2028
    Figure 3. Sodium Stibogluconate Product Picture
    Figure 4. Meglumine Antimoniate Product Picture
    Figure 5. Global Pentavalent Antimonials Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Pharmacies
    Figure 7. Retail Pharmacies
    Figure 8. Online Pharmacies
    Figure 9. Pentavalent Antimonials Report Years Considered
    Figure 10. Global Pentavalent Antimonials Sales 2017-2028 (g)
    Figure 11. Global Pentavalent Antimonials Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Pentavalent Antimonials Revenue 2017-2028 (US$ Million)
    Figure 13. Global Pentavalent Antimonials Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Pentavalent Antimonials Sales Market Share by Region (2017-2022)
    Figure 15. Global Pentavalent Antimonials Sales Market Share by Region (2023-2028)
    Figure 16. North America Pentavalent Antimonials Sales YoY (2017-2028) & (g)
    Figure 17. North America Pentavalent Antimonials Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Pentavalent Antimonials Sales YoY (2017-2028) & (g)
    Figure 19. Europe Pentavalent Antimonials Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Pentavalent Antimonials Sales YoY (2017-2028) & (g)
    Figure 21. Asia-Pacific Pentavalent Antimonials Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Pentavalent Antimonials Sales YoY (2017-2028) & (g)
    Figure 23. Latin America Pentavalent Antimonials Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Pentavalent Antimonials Sales YoY (2017-2028) & (g)
    Figure 25. Middle East & Africa Pentavalent Antimonials Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Pentavalent Antimonials Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Pentavalent Antimonials in the World: Market Share by Pentavalent Antimonials Revenue in 2021
    Figure 28. Global Pentavalent Antimonials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Pentavalent Antimonials Sales Market Share by Type (2017-2028)
    Figure 30. Global Pentavalent Antimonials Revenue Market Share by Type (2017-2028)
    Figure 31. Global Pentavalent Antimonials Sales Market Share by Application (2017-2028)
    Figure 32. Global Pentavalent Antimonials Revenue Market Share by Application (2017-2028)
    Figure 33. North America Pentavalent Antimonials Sales Market Share by Type (2017-2028)
    Figure 34. North America Pentavalent Antimonials Revenue Market Share by Type (2017-2028)
    Figure 35. North America Pentavalent Antimonials Sales Market Share by Application (2017-2028)
    Figure 36. North America Pentavalent Antimonials Revenue Market Share by Application (2017-2028)
    Figure 37. North America Pentavalent Antimonials Sales Share by Country (2017-2028)
    Figure 38. North America Pentavalent Antimonials Revenue Share by Country (2017-2028)
    Figure 39. U.S. Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Pentavalent Antimonials Sales Market Share by Type (2017-2028)
    Figure 42. Europe Pentavalent Antimonials Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Pentavalent Antimonials Sales Market Share by Application (2017-2028)
    Figure 44. Europe Pentavalent Antimonials Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Pentavalent Antimonials Sales Share by Country (2017-2028)
    Figure 46. Europe Pentavalent Antimonials Revenue Share by Country (2017-2028)
    Figure 47. Germany Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 48. France Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Pentavalent Antimonials Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Pentavalent Antimonials Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Pentavalent Antimonials Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Pentavalent Antimonials Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Pentavalent Antimonials Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Pentavalent Antimonials Revenue Share by Region (2017-2028)
    Figure 58. China Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 61. India Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Pentavalent Antimonials Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Pentavalent Antimonials Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Pentavalent Antimonials Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Pentavalent Antimonials Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Pentavalent Antimonials Sales Share by Country (2017-2028)
    Figure 73. Latin America Pentavalent Antimonials Revenue Share by Country (2017-2028)
    Figure 74. Mexico Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Pentavalent Antimonials Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Pentavalent Antimonials Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Pentavalent Antimonials Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Pentavalent Antimonials Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Pentavalent Antimonials Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Pentavalent Antimonials Revenue Share by Country (2017-2028)
    Figure 83. Turkey Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Pentavalent Antimonials Revenue (2017-2028) & (US$ Million)
    Figure 86. Pentavalent Antimonials Value Chain
    Figure 87. Pentavalent Antimonials Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed